Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Drug Substitution"" wg kryterium: Temat


Tytuł :
Optimal Timing of Switching from Platinum-based Chemotherapy to Pembrolizumab for Advanced Urothelial Carcinoma Based on Real-world Data: A Multi-institutional Retrospective Study.
Autorzy :
Furubayashi N; Department of Urology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan .
Morokuma F; Department of Urology, Saga-ken Medical Centre Koseikan, Saga, Japan.
Tomoda T; Department of Urology, Oita Prefectural Hospital, Oita, Japan.
Hori Y; Department of Urology, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan.
Negishi T; Department of Urology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Miura A; Department of Urology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Komori H; Department of Urology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Kuroiwa K; Department of Urology, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan.
Nakamura M; Department of Urology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2022 Mar; Vol. 42 (3), pp. 1571-1577.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Drug Substitution*/adverse effects
Drug Substitution*/mortality
Antibodies, Monoclonal, Humanized/*administration & dosage
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Carcinoma/*drug therapy
Immune Checkpoint Inhibitors/*administration & dosage
Urinary Bladder Neoplasms/*drug therapy
Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Carcinoma/mortality ; Carcinoma/pathology ; Female ; Humans ; Immune Checkpoint Inhibitors/adverse effects ; Japan ; Male ; Middle Aged ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome ; Urinary Bladder Neoplasms/mortality ; Urinary Bladder Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Therapeutic Basis of Generic Substitution of Antiseizure Medications.
Autorzy :
Elmer S; Department of Neuroscience and Experimental Therapeutics, Texas A&M University Health Science Center College of Medicine, Bryan, Texas.
Reddy DS; Department of Neuroscience and Experimental Therapeutics, Texas A&M University Health Science Center College of Medicine, Bryan, Texas .
Pokaż więcej
Źródło :
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2022 May; Vol. 381 (2), pp. 188-196. Date of Electronic Publication: 2022 Mar 03.
Typ publikacji :
Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Substitution*
Epilepsy*/drug therapy
Anticonvulsants/adverse effects ; Anticonvulsants/pharmacokinetics ; Drugs, Generic/adverse effects ; Humans ; Lamotrigine/therapeutic use ; Pharmaceutical Preparations ; Seizures/chemically induced ; Seizures/drug therapy
Czasopismo naukowe
Tytuł :
Switching to Over-the-Counter Availability of Rescue Inhalers for Asthma.
Autorzy :
Feldman WB; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Avorn J; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Kesselheim AS; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Pokaż więcej
Źródło :
JAMA [JAMA] 2022 Mar 15; Vol. 327 (11), pp. 1021-1022.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Substitution*
Asthma/*drug therapy
Bronchodilator Agents/*administration & dosage
Nonprescription Drugs/*administration & dosage
Administration, Inhalation ; Humans ; Nebulizers and Vaporizers
Czasopismo naukowe
Tytuł :
Mandatory nonmedical switching from originator to biosimilar infliximab in patients with inflammatory arthritis and psoriasis in British Columbia: a cohort study.
Autorzy :
Fisher A; Department of Anesthesiology, Pharmacology and Therapeutics (Fisher, Kim, Dormuth), University of British Columbia, Vancouver, BC .
Kim JD; Department of Anesthesiology, Pharmacology and Therapeutics (Fisher, Kim, Dormuth), University of British Columbia, Vancouver, BC.
Dormuth CR; Department of Anesthesiology, Pharmacology and Therapeutics (Fisher, Kim, Dormuth), University of British Columbia, Vancouver, BC.
Pokaż więcej
Źródło :
CMAJ open [CMAJ Open] 2022 Feb 15; Vol. 10 (1), pp. E109-E118. Date of Electronic Publication: 2022 Feb 15 (Print Publication: 2022).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Arthritis, Psoriatic*/drug therapy
Arthritis, Psoriatic*/epidemiology
Arthritis, Rheumatoid*/drug therapy
Arthritis, Rheumatoid*/epidemiology
Drug Substitution*/adverse effects
Drug Substitution*/methods
Drug Substitution*/statistics & numerical data
Spondylitis, Ankylosing*/drug therapy
Spondylitis, Ankylosing*/epidemiology
Biosimilar Pharmaceuticals/*therapeutic use
Infliximab/*therapeutic use
Adult ; Antirheumatic Agents/therapeutic use ; British Columbia/epidemiology ; Cohort Studies ; Drug Utilization Review/statistics & numerical data ; Female ; Humans ; Male ; Outcome Assessment, Health Care ; Practice Patterns, Physicians'/statistics & numerical data
Czasopismo naukowe
Tytuł :
Reducing the Risk of Withdrawal Symptoms and Relapse Following Clozapine Discontinuation-Is It Feasible to Develop Evidence-Based Guidelines?
Autorzy :
Blackman G; Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.; Psychosis Clinical Academic Group, South London and Maudsley NHS Foundation Trust, London, UK.
Oloyede E; Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.; Psychosis Clinical Academic Group, South London and Maudsley NHS Foundation Trust, London, UK.; Institute of Pharmaceutical Science, King's College London, London, UK.
Horowitz M; Division of Psychiatry, University College London, London, UK.; North East London NHS Foundation Trust, London, UK.
Harland R; Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.; Psychosis Clinical Academic Group, South London and Maudsley NHS Foundation Trust, London, UK.
Taylor D; Institute of Pharmaceutical Science, King's College London, London, UK.
MacCabe J; Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.; Psychosis Clinical Academic Group, South London and Maudsley NHS Foundation Trust, London, UK.
McGuire P; Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.; Psychosis Clinical Academic Group, South London and Maudsley NHS Foundation Trust, London, UK.
Pokaż więcej
Źródło :
Schizophrenia bulletin [Schizophr Bull] 2022 Jan 21; Vol. 48 (1), pp. 176-189.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Substitution*/methods
Drug Substitution*/standards
Practice Guidelines as Topic*/standards
Symptom Flare Up*
Antipsychotic Agents/*administration & dosage
Clozapine/*administration & dosage
Schizophrenia/*drug therapy
Substance Withdrawal Syndrome/*prevention & control
Adult ; Antipsychotic Agents/adverse effects ; Clinical Protocols ; Clozapine/adverse effects ; Evidence-Based Medicine ; Feasibility Studies ; Humans ; Schizophrenia, Treatment-Resistant/drug therapy ; Time Factors
Czasopismo naukowe
Tytuł :
Suicidal and self-injurious behavior following adalimumab reference-to-generic biosimilar switch.
Autorzy :
Ward C; King's College Hospital NHS Foundation Trust, King's College Hospital, London, UK.
Farag M; King's College Hospital NHS Foundation Trust, King's College Hospital, London, UK.
Pollak TA; King's College Hospital NHS Foundation Trust, King's College Hospital, London, UK.; South London and Maudsley NHS Foundation Trust, Maudsley Hospital, London, UK.; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Coutinho E; King's College Hospital NHS Foundation Trust, King's College Hospital, London, UK.
Posporelis S; King's College Hospital NHS Foundation Trust, King's College Hospital, London, UK.; South London and Maudsley NHS Foundation Trust, Maudsley Hospital, London, UK.
Pokaż więcej
Źródło :
Psychiatry and clinical neurosciences [Psychiatry Clin Neurosci] 2022 Feb; Vol. 76 (2), pp. 59-62. Date of Electronic Publication: 2021 Dec 07.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Biosimilar Pharmaceuticals*
Drug Substitution*
Self-Injurious Behavior*
Adalimumab ; Adult ; Drugs, Generic ; Humans ; Male ; Suicidal Ideation
Raport
Tytuł :
Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections.
Autorzy :
Roth RS; Division of Infectious Diseases, University Hospital of Geneva, Geneva, Switzerland.
Masouridi-Levrat S; Division of Hematology, Bone Marrow Transplant Unit, University Hospital of Geneva and faculty of Medicine, University of Geneva, Geneva, Switzerland.
Giannotti F; Division of Hematology, Bone Marrow Transplant Unit, University Hospital of Geneva and faculty of Medicine, University of Geneva, Geneva, Switzerland.
Mamez AC; Division of Hematology, Bone Marrow Transplant Unit, University Hospital of Geneva and faculty of Medicine, University of Geneva, Geneva, Switzerland.
Glambedakis E; Division of Infectious Diseases, University Hospital of Lausanne, Lausanne, Switzerland.
Lamoth F; Division of Infectious Diseases, University Hospital of Lausanne, Lausanne, Switzerland.
Bochud PY; Division of Infectious Diseases, University Hospital of Lausanne, Lausanne, Switzerland.
Erard V; Division of Infectious Diseases, Cantonal Hospital of Fribourg, Fribourg, Switzerland.
Emonet S; Division of Infectious Diseases, Cantonal Hospital of Sion and Institut Central des Hôpitaux (ICH), Sion, Switzerland.
Van Delden C; Division of Infectious Diseases, University Hospital of Geneva, Geneva, Switzerland.
Kaiser L; Division of Infectious Diseases, University Hospital of Geneva, Geneva, Switzerland.
Chalandon Y; Division of Hematology, Bone Marrow Transplant Unit, University Hospital of Geneva and faculty of Medicine, University of Geneva, Geneva, Switzerland.
Neofytos D; Division of Infectious Diseases, University Hospital of Geneva, Geneva, Switzerland.
Pokaż więcej
Źródło :
Mycoses [Mycoses] 2022 Feb; Vol. 65 (2), pp. 199-210. Date of Electronic Publication: 2021 Dec 29.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Substitution*
Hematopoietic Stem Cell Transplantation*/adverse effects
Invasive Fungal Infections*/drug therapy
Transplant Recipients*
Antifungal Agents/*therapeutic use
Adult ; Antifungal Agents/classification ; Cohort Studies ; Fungi ; Humans
Czasopismo naukowe
Tytuł :
Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study.
Autorzy :
Mazza S; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Gastroenterology and Endoscopy Unit, Milan, Italy.
Piazza O Sed N; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Gastroenterology and Endoscopy Unit, Milan, Italy.
Conforti FS; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Gastroenterology and Endoscopy Unit, Milan, Italy.
Fascì A; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Gastroenterology and Endoscopy Unit, Milan, Italy.; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Rimondi A; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Marinoni B; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Casini V; Gastroenterology Unit, Bolognini Hospital, Bergamo, Italy.
Ricci C; Department of Clinical and Experimental Sciences, University of Brescia, Spedali Civili, Brescia, Italy.
Munari F; Gastroenterology Unit, Bolognini Hospital, Bergamo, Italy.
Pirola L; Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
Invernizzi P; Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
Girelli C; Gastroenterology and Digestive Endoscopy Unit, Busto Arsizio Hospital, Varese, Italy.
Lupinacci G; Gastroenterology and Endoscopy Unit, Ospedale Maggiore, Crema, Italy.
Pastorelli L; Gastroenterology and Liver Unit, ASST Santi Paolo e Carlo, Ospedale San Paolo Milan, Italy.; Department of Health Sciences, Univeristà degli Studi di Milano, Milan, Italy.
Cavallaro F; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Gastroenterology and Endoscopy Unit, Milan, Italy.
Ferraris L; Gastroenterology and Endoscopy Unit, Gallarate Hospital, Varese, Italy.
Colucci A; Gastroenterology and Endoscopy Unit, Gallarate Hospital, Varese, Italy.
Amato A; Gastroenterology and Digestive Endoscopy Unit, Valduce Hospital, Como, Italy.
Eugenio Tontini G; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Gastroenterology and Endoscopy Unit, Milan, Italy.; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Vecchi M; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Gastroenterology and Endoscopy Unit, Milan, Italy.; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Fiorino G; IBD Center, Humanitas Clinical and Research Center, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Caprioli F; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Gastroenterology and Endoscopy Unit, Milan, Italy.; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Pokaż więcej
Źródło :
Clinical and translational science [Clin Transl Sci] 2022 Jan; Vol. 15 (1), pp. 172-181. Date of Electronic Publication: 2021 Sep 15.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Drug Substitution*
Treatment Outcome*
Antibodies, Monoclonal/*pharmacology
Antibodies, Monoclonal/*therapeutic use
Biosimilar Pharmaceuticals/*pharmacology
Biosimilar Pharmaceuticals/*therapeutic use
Inflammatory Bowel Diseases/*drug therapy
Infliximab/*pharmacology
Infliximab/*therapeutic use
Adolescent ; Adult ; Cohort Studies ; Female ; Humans ; Male ; Young Adult
Czasopismo naukowe
Tytuł :
Treatment Sequences After Discontinuing a Tumor Necrosis Factor Inhibitor in Patients With Rheumatoid Arthritis: A Comparison of Cycling Versus Swapping Strategies.
Autorzy :
Karpes Matusevich AR; School of Public Health, The University of Texas Health Science Center at Houston.
Duan Z; The University of Texas MD Anderson Cancer Center, Houston.
Zhao H; The University of Texas MD Anderson Cancer Center, Houston.
Lal LS; School of Public Health, The University of Texas Health Science Center at Houston.
Chan W; School of Public Health, The University of Texas Health Science Center at Houston.
Suarez-Almazor ME; The University of Texas MD Anderson Cancer Center, Houston.
Giordano SH; The University of Texas MD Anderson Cancer Center, Houston.
Swint JM; School of Public Health and McGovern School of Medicine, The University of Texas Health Science Center at Houston.
Lopez-Olivo MA; The University of Texas MD Anderson Cancer Center, Houston.
Pokaż więcej
Źródło :
Arthritis care & research [Arthritis Care Res (Hoboken)] 2021 Oct; Vol. 73 (10), pp. 1461-1469. Date of Electronic Publication: 2021 Aug 26.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Substitution*/adverse effects
Drug Substitution*/economics
Arthritis, Rheumatoid/*drug therapy
Tumor Necrosis Factor Inhibitors/*administration & dosage
Adult ; Aged ; Arthritis, Rheumatoid/diagnosis ; Arthritis, Rheumatoid/economics ; Arthritis, Rheumatoid/immunology ; Cost Savings ; Cost-Benefit Analysis ; Databases, Factual ; Drug Administration Schedule ; Drug Costs ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Time Factors ; Treatment Outcome ; Tumor Necrosis Factor Inhibitors/adverse effects ; Tumor Necrosis Factor Inhibitors/economics ; United States
Czasopismo naukowe
Tytuł :
Ticagrelor and prasugrel in acute coronary syndrome: a single-arm crossover platelet reactivity study.
Autorzy :
Verdoia M; Department of Translational Medicine.
Pergolini P; Clinical Chemistry, Azienda Ospedaliera-Universitaria 'Maggiore della Carità', Eastern Piedmont University, Novara, Italy.
Nardin M; Department of Translational Medicine.
Rolla R; Clinical Chemistry, Azienda Ospedaliera-Universitaria 'Maggiore della Carità', Eastern Piedmont University, Novara, Italy.
Suryapranata H; Department of Cardiology, UMC St Radboud, Nijmegen, The Netherlands.
Kedhi E; Department of Cardiology, Erasmus Hospital, University of Bruxelles, Brussels, Belgium.
De Luca G; Department of Translational Medicine.; Division of Cardiology, Azienda Ospedaliero-Universitaria Maggiore della Carità, Eastern Piedmont University, Novara, Italy.
Pokaż więcej
Corporate Authors :
Novara Atherosclerosis Study Group (NAS)
Źródło :
Journal of cardiovascular medicine (Hagerstown, Md.) [J Cardiovasc Med (Hagerstown)] 2021 Sep 01; Vol. 22 (9), pp. 686-692.
Typ publikacji :
Clinical Study; Journal Article
MeSH Terms :
Acute Coronary Syndrome*/blood
Acute Coronary Syndrome*/diagnosis
Acute Coronary Syndrome*/drug therapy
Acute Coronary Syndrome*/surgery
Drug Substitution*/methods
Drug Substitution*/statistics & numerical data
Prasugrel Hydrochloride*/administration & dosage
Prasugrel Hydrochloride*/pharmacokinetics
Ticagrelor*/administration & dosage
Ticagrelor*/pharmacokinetics
Percutaneous Coronary Intervention/*methods
Platelet Aggregation/*drug effects
Cross-Over Studies ; Drug Monitoring/methods ; Female ; Humans ; Male ; Middle Aged ; Outcome Assessment, Health Care ; Platelet Aggregation Inhibitors/administration & dosage ; Platelet Aggregation Inhibitors/pharmacokinetics ; Platelet Function Tests/methods
Czasopismo naukowe
Tytuł :
Outcome of Reverse Switching From CT-P13 to Originator Infliximab in Patients With Inflammatory Bowel Disease.
Autorzy :
Mahmmod S; Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, the Netherlands.
Schultheiss JPD; Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, the Netherlands.
van Bodegraven AA; Department of Gastroenterology and Hepatology, Zuyderland Medisch Centrum, Sittard, the Netherlands.
Dijkstra G; Department of Gastroenterology and Hepatology, University Medical Centre Groningen, Groningen, the Netherlands.
Gilissen LPL; Department of Gastroenterology and Hepatology, Catharina Ziekenhuis, Eindhoven, the Netherlands.
Hoentjen F; Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, the Netherlands.
Lutgens MWMD; Department of Gastroenterology and Hepatology, Elisabeth TweeSteden Ziekenhuis, Tilburg, the Netherlands.
Mahmmod N; Department of Gastroenterology and Hepatology, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands.
van der Meulen-de Jong AE; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, the Netherlands.
Smits LJT; Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, the Netherlands.
Tan ACITL; Department of Gastroenterology and Hepatology, Canisius-Wilhelmina Ziekenhuis, Nijmegen, the Netherlands.
Oldenburg B; Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, the Netherlands.
Fidder HH; Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, the Netherlands.
Pokaż więcej
Źródło :
Inflammatory bowel diseases [Inflamm Bowel Dis] 2021 Nov 15; Vol. 27 (12), pp. 1954-1962.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Antibodies, Monoclonal*/adverse effects
Antibodies, Monoclonal*/therapeutic use
Biosimilar Pharmaceuticals*/adverse effects
Biosimilar Pharmaceuticals*/therapeutic use
Drug Substitution*
Inflammatory Bowel Diseases*/drug therapy
Infliximab*/adverse effects
Infliximab*/therapeutic use
Adult ; Chronic Disease ; Female ; Gastrointestinal Agents/adverse effects ; Gastrointestinal Agents/therapeutic use ; Humans ; Male ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Evaluation of solid tumor response to sequential treatment cycles via a new computational hybrid approach.
Autorzy :
Moradi Kashkooli F; Department of Mechanical Engineering, K. N. Toosi University of Technology, Tehran, Iran.
Soltani M; Department of Mechanical Engineering, K. N. Toosi University of Technology, Tehran, Iran. .; Department of Electrical and Computer Engineering, University of Waterloo, Waterloo, ON, Canada. .; Cancer Biology Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran. .; Advanced Bioengineering Initiative Center, Computational Medicine Center, K. N. Toosi University of Technology, Tehran, Iran. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2021 Nov 02; Vol. 11 (1), pp. 21475. Date of Electronic Publication: 2021 Nov 02.
Typ publikacji :
Evaluation Study; Journal Article
MeSH Terms :
Drug Delivery Systems*
Drug Substitution*
Models, Theoretical*
Antineoplastic Combined Chemotherapy Protocols/*pharmacology
Neoplasms/*pathology
Administration, Metronomic ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Humans ; Maximum Tolerated Dose ; Neoplasms/drug therapy ; Tumor Cells, Cultured
Czasopismo naukowe
Tytuł :
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
Autorzy :
Mysler E; Organización Médica de Investigación, Buenos Aires, Argentina. .
Azevedo VF; Rheumatology Unit, Department of Internal Medicine, Federal University of Paraná, Curitiba, PR, Brazil.
Danese S; Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy.
Alvarez D; Pfizer Inc, Collegeville, PA, USA.
Iikuni N; Pfizer Inc, New York, NY, USA.
Ingram B; Pfizer Inc, Boston, MA, USA.
Mueller M; Pfizer Pharma GmbH, Berlin, Germany.
Peyrin-Biroulet L; Department of Gastroenterology and Inserm U1256 NGERE, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.
Pokaż więcej
Źródło :
Drugs [Drugs] 2021 Nov; Vol. 81 (16), pp. 1859-1879. Date of Electronic Publication: 2021 Oct 27.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Drug Substitution*
Biological Products/*administration & dosage
Biosimilar Pharmaceuticals/*administration & dosage
Animals ; Biological Products/adverse effects ; Biosimilar Pharmaceuticals/adverse effects ; Decision Making ; Humans ; Practice Patterns, Physicians'/trends ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł :
OpenSAFELY: impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic.
Autorzy :
Curtis HJ; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
MacKenna B; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Walker AJ; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Croker R; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Mehrkar A; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Morton C; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Bacon S; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Hickman G; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Inglesby P; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Bates C; TPP, Leeds, UK.
Evans D; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Ward T; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Cockburn J; TPP, Leeds, UK.
Davy S; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Bhaskaran K; Department of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Schultze A; Department of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Rentsch CT; Department of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Williamson E; Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK.
Hulme W; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Tomlinson L; Department of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Mathur R; Department of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Drysdale H; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Eggo RM; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Wong AY; Department of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Forbes H; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Parry J; TPP, Leeds, UK.
Hester F; TPP, Leeds, UK.
Harper S; TPP, Leeds, UK.
Douglas I; Department of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Smeeth L; Department of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Goldacre B; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK .
Pokaż więcej
Corporate Authors :
OpenSAFELY Collaborative
Źródło :
Open heart [Open Heart] 2021 Nov; Vol. 8 (2).
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19*
Anticoagulants/*administration & dosage
Blood Coagulation/*drug effects
Drug Substitution/*standards
Factor Xa Inhibitors/*administration & dosage
Practice Guidelines as Topic/*standards
Practice Patterns, Physicians'/*standards
State Medicine/*standards
Warfarin/*administration & dosage
Aged ; Anticoagulants/adverse effects ; Blood Coagulation Tests ; Drug Monitoring ; Drug Prescriptions ; Drug Substitution/adverse effects ; Drug Utilization/standards ; England ; Factor Xa Inhibitors/adverse effects ; Female ; Humans ; Male ; Middle Aged ; Patient Safety ; Primary Health Care/standards ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Warfarin/adverse effects
Czasopismo naukowe
Tytuł :
Reducing Benzodiazepine Exposure by Instituting a Guideline for Dexmedetomidine Usage in the NICU.
Autorzy :
Morton SU; Division of Newborn Medicine, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts .; Harvard Medical School, Harvard University, Boston, Massachusetts.
Labrecque M; Division of Newborn Medicine, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts.
Moline M; Division of Newborn Medicine, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts.
Hansen A; Division of Newborn Medicine, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts.; Harvard Medical School, Harvard University, Boston, Massachusetts.
Leeman K; Division of Newborn Medicine, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts.; Harvard Medical School, Harvard University, Boston, Massachusetts.
Pokaż więcej
Źródło :
Pediatrics [Pediatrics] 2021 Nov; Vol. 148 (5). Date of Electronic Publication: 2021 Oct 05.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Substitution*
Dexmedetomidine/*administration & dosage
Hypnotics and Sedatives/*administration & dosage
Midazolam/*administration & dosage
Airway Extubation ; Analgesics, Opioid/administration & dosage ; Bradycardia/chemically induced ; Dexmedetomidine/adverse effects ; Drug Administration Schedule ; Gestational Age ; Humans ; Hypnotics and Sedatives/adverse effects ; Hypotension/chemically induced ; Infant, Newborn ; Intensive Care Units, Neonatal ; Midazolam/adverse effects ; Morphine/administration & dosage ; Outcome Assessment, Health Care ; Quality Improvement ; Time Factors
Czasopismo naukowe
Tytuł :
Comparative clinical outcomes of insulin degludec and insulin glargine 300 U/mL after switching from other basal insulins in real-world patients with type 1 and type 2 diabetes.
Autorzy :
Oya J; Diabetes Center, Tokyo Women's Medical University, Tokyo, Japan.
Nakagami T; Diabetes Center, Tokyo Women's Medical University, Tokyo, Japan.
Hasegawa Y; Diabetes Center, Tokyo Women's Medical University, Tokyo, Japan.
Katamine A; Diabetes Center, Tokyo Women's Medical University, Tokyo, Japan.
Kondo Y; Diabetes Center, Tokyo Women's Medical University, Tokyo, Japan.
Babazono T; Diabetes Center, Tokyo Women's Medical University, Tokyo, Japan.
Pokaż więcej
Źródło :
Journal of diabetes investigation [J Diabetes Investig] 2021 Nov; Vol. 12 (11), pp. 1983-1991. Date of Electronic Publication: 2021 May 03.
Typ publikacji :
Comparative Study; Journal Article; Observational Study
MeSH Terms :
Drug Substitution*
Diabetes Mellitus, Type 1/*drug therapy
Diabetes Mellitus, Type 2/*drug therapy
Hypoglycemic Agents/*administration & dosage
Insulin Glargine/*administration & dosage
Insulin, Long-Acting/*administration & dosage
Adult ; Aged ; Body Mass Index ; Diabetes Mellitus, Type 1/blood ; Diabetes Mellitus, Type 2/blood ; Female ; Glycated Hemoglobin A/drug effects ; Humans ; Insulins/administration & dosage ; Japan ; Logistic Models ; Male ; Middle Aged ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Switch from rasagiline to safinamide in fluctuating Parkinson's disease patients: a retrospective, pilot study.
Autorzy :
Bianchini E; Dipartimento di Neuroscienze, Salute Mentale e Organi di Senso, 'Sapienza' Università di Roma, Rome, Italy.
Sforza M; Dipartimento di Neuroscienze, Salute Mentale e Organi di Senso, 'Sapienza' Università di Roma, Rome, Italy.
Rinaldi D; Dipartimento di Neuroscienze, Salute Mentale e Organi di Senso, 'Sapienza' Università di Roma, Rome, Italy.
Alborghetti M; Dipartimento di Neuroscienze, Salute Mentale e Organi di Senso, 'Sapienza' Università di Roma, Rome, Italy.; Dipartimento di Neurologia Clinica e Comportamentale, Fondazione Santa Lucia, IRCCS, Rome, Italy.
De Carolis L; Dipartimento di Neuroscienze, Salute Mentale e Organi di Senso, 'Sapienza' Università di Roma, Rome, Italy.
Della Gatta F; Dipartimento di Neuroscienze, Salute Mentale e Organi di Senso, 'Sapienza' Università di Roma, Rome, Italy.
Pontieri FE; Dipartimento di Neuroscienze, Salute Mentale e Organi di Senso, 'Sapienza' Università di Roma, Rome, Italy.; Dipartimento di Neurologia Clinica e Comportamentale, Fondazione Santa Lucia, IRCCS, Rome, Italy.
Pokaż więcej
Źródło :
Neurological research [Neurol Res] 2021 Nov; Vol. 43 (11), pp. 950-954. Date of Electronic Publication: 2021 Jun 18.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Drug Substitution*
Alanine/*analogs & derivatives
Antiparkinson Agents/*therapeutic use
Benzylamines/*therapeutic use
Indans/*therapeutic use
Parkinson Disease/*drug therapy
Aged ; Alanine/therapeutic use ; Female ; Humans ; Male ; Middle Aged ; Pilot Projects ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Knowledge, perceptions and practices of pharmacists regarding generic substitution in China: a cross-sectional study.
Autorzy :
Qu J; Department of Pharmacy, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Beijing, China.
Zuo W; Department of Pharmacy, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Beijing, China.
Wang S; Department of Pharmacy, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Beijing, China.
Du L; Department of Pharmacy, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Beijing, China.
Liu X; Department of Pharmacy, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Beijing, China.
Gao Y; Department of Pharmacy, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Beijing, China.
Li J; Department of Pharmacy, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Beijing, China.
Pan H; Department of Medical Administration, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Beijing, China.
Du X; Department of Pharmacy, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Beijing, China.
Mei D; Department of Pharmacy, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Beijing, China.
Took RL; Department of Pharmacy Practice, St. Louis College of Pharmacy, St Louis, Missouri, USA.
Schafermeyer KW; Department of Pharmaceutical and Administrative Sciences, St. Louis College of Pharmacy, St Louis, Missouri, USA.
Lukas S; Department of Pharmaceutical and Administrative Sciences, St. Louis College of Pharmacy, St Louis, Missouri, USA.
Zhang B; Department of Pharmacy, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Beijing, China .
Pokaż więcej
Źródło :
BMJ open [BMJ Open] 2021 Oct 18; Vol. 11 (10), pp. e051277. Date of Electronic Publication: 2021 Oct 18.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Substitution*
Pharmacists*
Cross-Sectional Studies ; Health Knowledge, Attitudes, Practice ; Humans ; Perception ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
Generic Substitution and Advice to Patients -Potential Legal Medicine Consequences - From A (Australia) to U (United Kingdom or United States of America).
Autorzy :
Beran RG; Conjoint Professor, South Western Clinical School, University of New South Wales, Sydney, NSW, Australia; Professor, Medical School, Griffith University, Broadbeach, Qld, Australia; Professor, Chair, Medical Law, Sechenov, Moscow First State University, Moscow, Russia. Electronic address: .
Pokaż więcej
Źródło :
Seizure [Seizure] 2021 Oct; Vol. 91, pp. 515-519. Date of Electronic Publication: 2021 Mar 17.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Drug Substitution*
Drugs, Generic*/therapeutic use
Forensic Medicine ; Humans ; Therapeutic Equivalency ; United Kingdom ; United States
Czasopismo naukowe
Tytuł :
Unanticipated Consequences of Switching to Sugammadex: Anesthesia Provider Survey on the Hormone Contraceptive Drug Interaction.
Autorzy :
Dwan RL; From the Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.
Raymond BL
Richardson MG
Pokaż więcej
Źródło :
Anesthesia and analgesia [Anesth Analg] 2021 Oct 01; Vol. 133 (4), pp. 958-966.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Anesthesiologists*
Drug Substitution*
Contraceptive Agents, Hormonal/*therapeutic use
Neuromuscular Agents/*adverse effects
Neuromuscular Blocking Agents/*antagonists & inhibitors
Progesterone/*therapeutic use
Sugammadex/*adverse effects
Contraceptive Agents, Hormonal/metabolism ; Drug Implants ; Drug Interactions ; Female ; Health Care Surveys ; Humans ; Intrauterine Devices, Medicated ; Progesterone/metabolism ; Risk Assessment ; Risk Factors ; Sugammadex/metabolism
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies